Leon H. Kircik

Dermatology

1425 Madison Ave
New York, NY 10029

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 363 publications

Treatment Adherence in Patients With Acne Vulgaris: A Narrative Review.

Treatment Adherence in Patients With Acne Vulgaris: A Narrative Review.

Journal: Journal of drugs in dermatology : JDD

Published: September 04, 2026

: Interleukin-31 in Atopic Dermatitis and Prurigo Nodularis: Pathophysiology, Neuroimmune Mechanisms, and Clinical Efficacy of Nemolizumab.

: Interleukin-31 in Atopic Dermatitis and Prurigo Nodularis: Pathophysiology, Neuroimmune Mechanisms, and Clinical Efficacy of Nemolizumab.

Journal: Journal of drugs in dermatology : JDD

Published: September 04, 2026

Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne: Pooled Analysis by Age and Sex.

Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne: Pooled Analysis by Age and Sex.

Journal: Journal of drugs in dermatology : JDD

Published: August 05, 2026

INDIVIDUAL ARTICLE: Generalized Pustular Psoriasis: A Contemporary Review of Diagnosis, Pathophysiology, and IL-36 Pathway-Directed Management.

INDIVIDUAL ARTICLE: Generalized Pustular Psoriasis: A Contemporary Review of Diagnosis, Pathophysiology, and IL-36 Pathway-Directed Management.

Journal: Journal of drugs in dermatology : JDD

Published: August 05, 2026

Efficacy and Safety of Clascoterone Cream 1% and Adapalene Gel 0.3% in Patients With Acne.

Efficacy and Safety of Clascoterone Cream 1% and Adapalene Gel 0.3% in Patients With Acne.

Journal: Journal of drugs in dermatology : JDD

Published: June 03, 2026

Efficacy and Safety of Clascoterone Cream 1% and Clindamycin 1.2%/Benzoyl Peroxide 5% Gel Treatment in Patients With Acne.

Efficacy and Safety of Clascoterone Cream 1% and Clindamycin 1.2%/Benzoyl Peroxide 5% Gel Treatment in Patients With Acne.

Journal: Journal of drugs in dermatology : JDD

Published: June 03, 2026

INDIVIDUAL ARTICLE: Clinical and Real-World Implications of IL-17 Receptor Blockade in Plaque Psoriasis and Psoriatic Arthritis With Brodalumab.

INDIVIDUAL ARTICLE: Clinical and Real-World Implications of IL-17 Receptor Blockade in Plaque Psoriasis and Psoriatic Arthritis With Brodalumab.

Journal: Journal of drugs in dermatology : JDD

Published: May 04, 2026

Malassezia Folliculitis Presentation, Diagnosis, and Treatment: A Review of "Fungal Acne".

Malassezia Folliculitis Presentation, Diagnosis, and Treatment: A Review of "Fungal Acne".

Journal: Journal of drugs in dermatology : JDD

Published: May 04, 2026

Raising the bar of efficacy in Atopic Dermatitis: deep response in week 16 responders treated with lebrikizumab over 2 years.

Raising the bar of efficacy in Atopic Dermatitis: deep response in week 16 responders treated with lebrikizumab over 2 years.

Journal: The Journal of dermatological treatment

Published: March 12, 2026

Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements from an Expert Panel.

Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements from an Expert Panel.

Journal: Journal of drugs in dermatology : JDD

Published: March 11, 2026

Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema.

Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema.

Journal: Journal of drugs in dermatology : JDD

Published: March 04, 2026

Brodalumab's 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World Evidence.

Brodalumab's 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World Evidence.

Journal: Journal of drugs in dermatology : JDD

Published: March 04, 2026

Showing 1-12 of 363

Last Updated: 09/26/2026